Insight Molecular Diagnostics Inc. — Director's Dealing 2024

Apr 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oncocyte Corp (OCX)
CIK: 0001642380
Period of Report: 2024-04-11

Reporting Person: Arno Andrew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-11	Common Stock, no par value	P	33898	$2.95	Acquired	69054	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, no par value	7804	Indirect
Common Stock, no par value	7804	Indirect

Footnotes

F1: Reflects shares of the Issuer's common stock, no par value ("Common Stock"), purchased by the Reporting Person from the Issuer in a private offering.

F2: These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.

F3: These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.